1.37BUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US03209R1032
CUSIP
03209R103
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
8.93
PEG Ratio
2.77
Book Value
15.38
Dividend Share
-
Dividend Yield
-
Earnings Share
3.06
Wall Street Target Price
39.80
EPS Estimate Current Year
3.00
EPS Estimate Next Year
3.84
EPS Estimate Current Quarter
0.9383
EPS Estimate Next Quarter
0.8775
Most Recent Quarter
-
Revenue TTM
731,966,976
Gross Profit TTM
373,855,008
EBITDA
258,386,000
Profit Margin
21.79%
Return On Assets TTM
8.31%
Return On Equity TTM
23.26%
Revenue Per Share TTM
15.114
Qtly Revenue Growth YOY
4.70%
Diluted Eps TTM
3.06
Qtly Earnings Growth YOY
7.20%
Trailing PE
8.93
Forward PE
0
Price Sales TTM
1.7791
Price Book MRQ
1.7764
Enterprise Value Revenue
2
Enterprise Value EBITDA
6
16.65
3.38%131.25
0.00%41.30
0.00%14.80
0.00%31.22
0.00%142.76
-5.18%5.08
-2.03%161.60
-1.75%14.79
-0.77%29.15
-0.51%